Sanofi (France) (SAN.PA) Plots 186 Net Job Cuts in French R&D, 453 Transfers to Other Sites According to Memo

Sanofi, trying to squeeze more out of R&D spending like other big drugmakers, is finding its home market France a difficult place to cut costs because of complex labour laws, union opposition and a government eager to protect jobs. The company, which scaled back job cut plans in France a year ago due to political pressure, will start a new round of talks with unions on Tuesday that are likely to be tough.